Chronic kidney disease: the global challenge

被引:903
作者
El Nahas, AM [1 ]
Bello, AK [1 ]
机构
[1] Univ Sheffield, Sheffield Teaching Hosp NHS Fdn Trust, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England
关键词
D O I
10.1016/S0140-6736(05)17789-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The worldwide rise in the number of patients with chronic kidney disease (CKD) and consequent end-stage renal failure necessitating renal replacement therapy is threatening to reach epidemic proportions over the next decade, and only a small number of countries have robust economies able to meet the challenges posed. A change in global approach to CKD from treatment of end-stage renal disease (ESRD) to much more aggressive primary and secondary prevention is therefore imperative. In this Seminar, we examine the epidemiology of CKD worldwide, with emphasis on early detection and prevention, and the feasibility of methods for detection and primary prevention of CKD. We also review the risk factors and markers of progressive CKD. We explore current understanding of the mechanisms underlying renal scarring leading to ESRD to inform on current and future interventions as well as evidence relating to interventions to slow the progression of CKD. Finally, we make strategic recommendations based on future research to stem the worldwide growth of CKD. Consideration is given to health economics. A global and concerted approach to CKD must be adopted in both more and less developed countries to avoid a major catastrophe.
引用
收藏
页码:331 / 340
页数:10
相关论文
共 104 条
  • [21] Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: costs and reimbursement/funding of ESRD therapies
    De Vecchi, AF
    Dratwa, M
    Wiedemann, ME
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 : 31 - 41
  • [22] Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703
  • [23] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword
    Eknoyan, G
    Levin, NW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : S14 - S266
  • [24] Plasticity of kidney cells: Role in kidney remodeling and scarring
    El Nahas, AM
    [J]. KIDNEY INTERNATIONAL, 2003, 64 (05) : 1553 - 1563
  • [25] ELNAHAS AM, 1988, NEPHROLOGY, V2, P1206
  • [26] Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro
    Fan, JM
    Ng, YY
    Hill, PA
    Nikolic-Paterson, DJ
    Mu, W
    Atkins, RC
    Lan, HY
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (04) : 1455 - 1467
  • [27] The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods
    Feldman, HI
    Appel, LJ
    Chertow, GM
    Cifelli, D
    Cizman, B
    Daugirdas, J
    Fink, JC
    Franklin-Becker, ED
    Go, AS
    Hamm, LL
    He, JA
    Hostetter, T
    Hsu, CY
    Jamerson, K
    Joffe, M
    Kusek, JW
    Landis, JR
    Lash, JP
    Miller, ER
    Mohler, ER
    Muntner, P
    Ojo, AO
    Rahman, M
    Townsend, RR
    Wright, JT
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : S148 - S153
  • [28] Smad3 as a mediator of the fibrotic response
    Flanders, KC
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2004, 85 (02) : 47 - 64
  • [29] Frame P S, 1975, J Fam Pract, V2, P189
  • [30] Effect of lipid reduction on the progression of renal disease: A meta-analysis
    Fried, LF
    Orchard, TJ
    Kasiske, BL
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (01) : 260 - 269